These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 21302807)
1. Hepatoma-derived growth factor regulates the bad-mediated apoptotic pathway and induction of vascular endothelial growth factor in stomach cancer cells. Lee KH; Choi EY; Kim MK; Lee SH; Jang BI; Kim TN; Kim SW; Kim SW; Song SK; Kim JR; Jung BC Oncol Res; 2010; 19(2):67-76. PubMed ID: 21302807 [TBL] [Abstract][Full Text] [Related]
2. Downregulation of hepatoma-derived growth factor activates the Bad-mediated apoptotic pathway in human cancer cells. Tsang TY; Tang WY; Tsang WP; Co NN; Kong SK; Kwok TT Apoptosis; 2008 Sep; 13(9):1135-47. PubMed ID: 18651222 [TBL] [Abstract][Full Text] [Related]
3. Mechanistic study on growth suppression and apoptosis induction by targeting hepatoma-derived growth factor in human hepatocellular carcinoma HepG2 cells. Tsang TY; Tang WY; Tsang WP; Co NN; Kong SK; Kwok TT Cell Physiol Biochem; 2009; 24(3-4):253-62. PubMed ID: 19710540 [TBL] [Abstract][Full Text] [Related]
4. Down-regulation of hepatoma-derived growth factor inhibits anchorage-independent growth and invasion of non-small cell lung cancer cells. Zhang J; Ren H; Yuan P; Lang W; Zhang L; Mao L Cancer Res; 2006 Jan; 66(1):18-23. PubMed ID: 16397209 [TBL] [Abstract][Full Text] [Related]
5. Hepatocyte growth factor promotes cell survival by phosphorylation of BAD in gastric cancer cells. Lee KH; Choi EY; Kim MK; Hyun MS; Eun JR; Jang BI; Kim TN; Kim SW; Song SK; Kim JH; Kim JR Oncol Res; 2008; 17(1):23-32. PubMed ID: 18488712 [TBL] [Abstract][Full Text] [Related]
6. Hepatoma-derived growth factor induces tumorigenesis in vivo through both direct angiogenic activity and induction of vascular endothelial growth factor. Okuda Y; Nakamura H; Yoshida K; Enomoto H; Uyama H; Hirotani T; Funamoto M; Ito H; Everett AD; Hada T; Kawase I Cancer Sci; 2003 Dec; 94(12):1034-41. PubMed ID: 14662017 [TBL] [Abstract][Full Text] [Related]
7. Hepatoma-derived growth factor promotes growth and metastasis of hepatocellular carcinoma cells. Yang GY; Zhang AQ; Wang J; Li CH; Wang XQ; Pan K; Zhou C; Dong JH Cell Biochem Funct; 2016 Jun; 34(4):274-85. PubMed ID: 27273265 [TBL] [Abstract][Full Text] [Related]
8. RhoGDI2 is associated with HGF-mediated tumor invasion through VEGF in stomach cancer. Koh SA; Kim MK; Lee KH; Kim SW; Kim JR Clin Exp Metastasis; 2014 Oct; 31(7):805-15. PubMed ID: 25253431 [TBL] [Abstract][Full Text] [Related]
9. Hepatoma-derived growth factor: A survival-related protein in prostate oncogenesis and a potential target for vitamin K2. Shetty A; Dasari S; Banerjee S; Gheewala T; Zheng G; Chen A; Kajdacsy-Balla A; Bosland MC; Munirathinam G Urol Oncol; 2016 Nov; 34(11):483.e1-483.e8. PubMed ID: 27692835 [TBL] [Abstract][Full Text] [Related]
10. Hepatoma-derived growth factor and its role in keloid pathogenesis. Ooi BN; Mukhopadhyay A; Masilamani J; Do DV; Lim CP; Cao XM; Lim IJ; Mao L; Ren HN; Nakamura H; Phan TT J Cell Mol Med; 2010 Jun; 14(6A):1328-37. PubMed ID: 19432814 [TBL] [Abstract][Full Text] [Related]
11. Down-regulation of survivin suppresses uro-plasminogen activator through transcription factor JunB. Lee KH; Choi EY; Koh SA; Kim MK; Kim KO; Lee SH; Jang BI; Kim SW; Kim SW; Song SK; Choi JH; Kim JR Exp Mol Med; 2011 Sep; 43(9):501-9. PubMed ID: 21734448 [TBL] [Abstract][Full Text] [Related]
12. The regulatory role of hepatoma-derived growth factor as an angiogenic factor in the eye. LeBlanc ME; Wang W; Chen X; Ji Y; Shakya A; Shen C; Zhang C; Gonzalez V; Brewer M; Ma JX; Wen R; Zhang F; Li W Mol Vis; 2016; 22():374-86. PubMed ID: 27122967 [TBL] [Abstract][Full Text] [Related]
13. Hepatoma-derived growth factor is a pulmonary endothelial cell-expressed angiogenic factor. Everett AD; Narron JV; Stoops T; Nakamura H; Tucker A Am J Physiol Lung Cell Mol Physiol; 2004 Jun; 286(6):L1194-201. PubMed ID: 14751852 [TBL] [Abstract][Full Text] [Related]
14. Various effects of hepatoma-derived growth factor on cell growth, migration and invasion of breast cancer and prostate cancer cells. Guo Z; He Y; Wang S; Zhang A; Zhao P; Gao C; Cao B Oncol Rep; 2011 Aug; 26(2):511-7. PubMed ID: 21567096 [TBL] [Abstract][Full Text] [Related]
15. Kiss-1 suppresses MMP-9 expression by activating p38 MAP kinase in human stomach cancer. Lee KH; Kim JR Oncol Res; 2009; 18(2-3):107-16. PubMed ID: 20066900 [TBL] [Abstract][Full Text] [Related]
16. Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer. Lian J; Tang J; Shi H; Li H; Zhen T; Xie W; Zhang F; Yang Y; Han A Oncotarget; 2015 Oct; 6(30):29357-74. PubMed ID: 26296979 [TBL] [Abstract][Full Text] [Related]
17. Apoptosis of human colorectal carcinoma cells is induced by blocking hepatoma-derived growth factor. Liao F; Dong W; Fan L Med Oncol; 2010 Dec; 27(4):1219-26. PubMed ID: 19924574 [TBL] [Abstract][Full Text] [Related]
18. Hepatocyte growth factor-mediated gastrin-releasing peptide induces IL-8 expression through Ets-1 in gastric cancer cells. Lee KH; Koh SA; Kim JR Oncol Res; 2013; 20(9):393-402. PubMed ID: 23924923 [TBL] [Abstract][Full Text] [Related]
19. Expression of hepatoma-derived growth factor is correlated with lymph node metastasis and prognosis of gastric carcinoma. Yamamoto S; Tomita Y; Hoshida Y; Takiguchi S; Fujiwara Y; Yasuda T; Doki Y; Yoshida K; Aozasa K; Nakamura H; Monden M Clin Cancer Res; 2006 Jan; 12(1):117-22. PubMed ID: 16397032 [TBL] [Abstract][Full Text] [Related]
20. Clinical and biological significance of hepatoma-derived growth factor in Ewing's sarcoma. Yang Y; Li H; Zhang F; Shi H; Zhen T; Dai S; Kang L; Liang Y; Wang J; Han A J Pathol; 2013 Nov; 231(3):323-34. PubMed ID: 23878072 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]